Extract notice to the Minister
Ebglyss (dermatite atopique)
Common name / Subject : lébrikizumab
Name of the manufacturer : Lilly
Form : Sol. Inj. S.C. (ser) (stylo)
Dosage : 125 mg/ml (2 ml)
Name of the manufacturer : Lilly
Form : Sol. Inj. S.C. (ser) (stylo)
Dosage : 125 mg/ml (2 ml)
Indication : Dermatite atopique modérée à grave
INESSS' Recommendation
Modification d'une indication reconnue
Minister's decisions
À venir
Evaluation published on October 29, 2025